SeaStar Medical Holding annual r&d spending
2021
2022
2023
2024
2025
SeaStar Medical Holding R&D Spending Growth & History (ICU)
SeaStar Medical Holding's r&d spending was $7.5M for fiscal 2025.
View full SeaStar Medical Holding company overviewSeaStar Medical Holding annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.5M | −$1.6M | −17.43% |
| 2024 | 2024-12-31 | $9.1M | $3.1M | +52.44% |
| 2023 | 2023-12-31 | $6.0M | $3.5M | +138.63% |
| 2022 | 2022-12-31 | $2.5M | −$263,000 | −9.51% |
| 2021 | 2021-12-31 | $2.8M | — | — |
SeaStar Medical Holding quarterly r&d spending
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.5M | $1.5M | +143.01% |
| Q1 2026 | 2026-03-31 | $2.3M | −$87,000 | −3.58% |
| Q4 2025 | 2025-12-31 | $2.2M | −$538,000 | −19.65% |
| Q3 2025 | 2025-09-30 | $1.9M | −$486,000 | −20.80% |
| Q2 2025 | 2025-06-30 | $1.0M | −$1.3M | −55.57% |
| Q1 2025 | 2025-03-31 | $2.4M | $734,000 | +43.25% |
| Q4 2024 | 2024-12-31 | $2.7M | $1.6M | +133.02% |
| Q3 2024 | 2024-09-30 | $2.3M | $1.2M | +114.90% |
| Q2 2024 | 2024-06-30 | $2.3M | $353,000 | +17.82% |
| Q1 2024 | 2024-03-31 | $1.7M | −$33,000 | −1.91% |
| Q4 2023 | 2023-12-31 | $1.2M | $350,000 | +42.42% |
| Q3 2023 | 2023-09-30 | $1.1M | $360,000 | +49.52% |
| Q2 2023 | 2023-06-30 | $2.0M | $1.4M | +232.38% |
| Q1 2023 | 2023-03-31 | $1.7M | $1.4M | +387.32% |
| Q4 2022 | 2022-12-31 | $825,000 | — | — |
| Q3 2022 | 2022-09-30 | $727,000 | — | — |
| Q2 2022 | 2022-06-30 | $596,000 | — | — |
| Q1 2022 | 2022-03-31 | $355,000 | — | — |
SeaStar Medical Holding r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, SeaStar Medical Holding's r&d spending increased from $2.8M to $7.5M, a change of $4.8M. The latest reported quarter, Q2 2026, shows $2.5M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SeaStar Medical Holding source filings ↗